Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced Gastric Cancer Published in Nature ...
HONG KONG, Jan. 23, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) is excited to announce that the prestigious medical journal Nature Medicine published the results of the company’s independently developed PD-1/CTLA-4 …